APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral TYK2 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral TYK2 Inhibitors Industry Growth and Trends Forecast to 2032

28 December 202593 pages

Choose your research edition.

Industry ResearchOral TYK2 Inhibitors Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral TYK2 Inhibitors Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Oral TYK2 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral TYK2 Inhibitors Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral TYK2 Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral TYK2 Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral TYK2 Inhibitors include Bristol Myers Squibb, Galapagos NV, Takeda (Nimbus Therapeutics), Ventyx Biosciences, Changzhou Hengbang Pharmaceutical, Highlightll Pharma, InnoCare and Inventisbio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral TYK2 Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral TYK2 Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral TYK2 Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral TYK2 Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral TYK2 Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral TYK2 Inhibitors Market by Company

Bristol Myers Squibb

Galapagos NV

Takeda (Nimbus Therapeutics)

Ventyx Biosciences

Changzhou Hengbang Pharmaceutical

Highlightll Pharma

InnoCare

Inventisbio

Oral TYK2 Inhibitors Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

Oral TYK2 Inhibitors Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

Oral TYK2 Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral TYK2 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral TYK2 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral TYK2 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral TYK2 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral TYK2 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single-target Inhibitors Table 2. Major Company of Dual-target Inhibitors Table 3. Global Oral TYK2 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 5. Global Oral TYK2 Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral TYK2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral TYK2 Inhibitors Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral TYK2 Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 9. Global Oral TYK2 Inhibitors Sales by Type (2027-2032) & (K Units) Table 10. Global Oral TYK2 Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral TYK2 Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral TYK2 Inhibitors Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral TYK2 Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 14. North America Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 15. North America Oral TYK2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 17. Europe Oral TYK2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Oral TYK2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. Latin America Oral TYK2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Oral TYK2 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. Oral TYK2 Inhibitors Industry Trends Table 25. Oral TYK2 Inhibitors Industry Drivers Table 26. Oral TYK2 Inhibitors Industry Opportunities and Challenges Table 27. Oral TYK2 Inhibitors Industry Restraints Table 28. Global Oral TYK2 Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral TYK2 Inhibitors Revenue Market Share by Company (2021-2026) Table 30. Global Oral TYK2 Inhibitors Sales by Company (2021-2026) & (K Units) Table 31. Global Oral TYK2 Inhibitors Sales Share by Company (2021-2026) Table 32. Global Oral TYK2 Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Oral TYK2 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral TYK2 Inhibitors Major Company Production Sites and Headquarters Table 35. Global Oral TYK2 Inhibitors Company, Product Type & Application Table 36. Global Oral TYK2 Inhibitors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral TYK2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral TYK2 Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral TYK2 Inhibitors Sales by Region (2021-2026) & (K Units) Table 41. Global Oral TYK2 Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral TYK2 Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral TYK2 Inhibitors Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral TYK2 Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Oral TYK2 Inhibitors Sales by Region (2027-2032) & (K Units) Table 46. Global Oral TYK2 Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral TYK2 Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral TYK2 Inhibitors Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral TYK2 Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Oral TYK2 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 52. Global Oral TYK2 Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral TYK2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral TYK2 Inhibitors Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral TYK2 Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 56. Global Oral TYK2 Inhibitors Sales by Application (2027-2032) & (K Units) Table 57. Global Oral TYK2 Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral TYK2 Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral TYK2 Inhibitors Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral TYK2 Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 61. North America Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 62. North America Oral TYK2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 64. Europe Oral TYK2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Oral TYK2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. Latin America Oral TYK2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Oral TYK2 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Bristol Myers Squibb Company Information Table 72. Bristol Myers Squibb Business Overview Table 73. Bristol Myers Squibb Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolio Table 75. Bristol Myers Squibb Recent Development Table 76. Galapagos NV Company Information Table 77. Galapagos NV Business Overview Table 78. Galapagos NV Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Galapagos NV Oral TYK2 Inhibitors Product Portfolio Table 80. Galapagos NV Recent Development Table 81. Takeda (Nimbus Therapeutics) Company Information Table 82. Takeda (Nimbus Therapeutics) Business Overview Table 83. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolio Table 85. Takeda (Nimbus Therapeutics) Recent Development Table 86. Ventyx Biosciences Company Information Table 87. Ventyx Biosciences Business Overview Table 88. Ventyx Biosciences Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolio Table 90. Ventyx Biosciences Recent Development Table 91. Changzhou Hengbang Pharmaceutical Company Information Table 92. Changzhou Hengbang Pharmaceutical Business Overview Table 93. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolio Table 95. Changzhou Hengbang Pharmaceutical Recent Development Table 96. Highlightll Pharma Company Information Table 97. Highlightll Pharma Business Overview Table 98. Highlightll Pharma Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Highlightll Pharma Oral TYK2 Inhibitors Product Portfolio Table 100. Highlightll Pharma Recent Development Table 101. InnoCare Company Information Table 102. InnoCare Business Overview Table 103. InnoCare Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. InnoCare Oral TYK2 Inhibitors Product Portfolio Table 105. InnoCare Recent Development Table 106. Inventisbio Company Information Table 107. Inventisbio Business Overview Table 108. Inventisbio Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Inventisbio Oral TYK2 Inhibitors Product Portfolio Table 110. Inventisbio Recent Development Table 111. North America Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 113. North America Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026) Table 114. North America Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Oral TYK2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 116. North America Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Oral TYK2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Oral TYK2 Inhibitors Market Share by Country (2021-2026) Table 119. North America Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Oral TYK2 Inhibitors Market Share Forecast by Country (2027-2032) Table 121. Europe Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 123. Europe Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026) Table 124. Europe Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Oral TYK2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Oral TYK2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Oral TYK2 Inhibitors Market Share by Country (2021-2026) Table 129. Europe Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Oral TYK2 Inhibitors Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Oral TYK2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Oral TYK2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Oral TYK2 Inhibitors Market Share by Country (2021-2026) Table 139. Asia-Pacific Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Oral TYK2 Inhibitors Market Share Forecast by Country (2027-2032) Table 141. Latin America Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 143. Latin America Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026) Table 144. Latin America Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Oral TYK2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Oral TYK2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Oral TYK2 Inhibitors Market Share by Country (2021-2026) Table 149. Latin America Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Oral TYK2 Inhibitors Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Oral TYK2 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Oral TYK2 Inhibitors Market Share by Country (2021-2026) Table 159. Middle East and Africa Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Oral TYK2 Inhibitors Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Oral TYK2 Inhibitors Distributors List Table 164. Oral TYK2 Inhibitors Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Oral TYK2 Inhibitors Image Figure 2. Global Oral TYK2 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral TYK2 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral TYK2 Inhibitors Sales (2021-2032) & (K Units) Figure 5. Single-target Inhibitors Image Figure 6. Global Single-target Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Dual-target Inhibitors Image Figure 8. Global Dual-target Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Oral TYK2 Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral TYK2 Inhibitors Market Share by Type 2025 VS 2032 Figure 11. North America Oral TYK2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral TYK2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral TYK2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral TYK2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral TYK2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral TYK2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral TYK2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral TYK2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral TYK2 Inhibitors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Psoriasis Image Figure 24. Global Psoriasis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Systemic Lupus Erythematosus Image Figure 26. Global Systemic Lupus Erythematosus Sales YoY Growth (2021-2032) & (K Units) Figure 27. Dermatitis Image Figure 28. Global Dermatitis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Arthritis Image Figure 30. Global Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Oral TYK2 Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Oral TYK2 Inhibitors Market Share by Application 2025 VS 2032 Figure 35. North America Oral TYK2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. North America Oral TYK2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Europe Oral TYK2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Europe Oral TYK2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Oral TYK2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Oral TYK2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Latin America Oral TYK2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Oral TYK2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share in Value by Application in 2025 Figure 45. North America Oral TYK2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Oral TYK2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Oral TYK2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oral TYK2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Oral TYK2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Oral TYK2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oral TYK2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Oral TYK2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Oral TYK2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oral TYK2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Oral TYK2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Oral TYK2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oral TYK2 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Oral TYK2 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Oral TYK2 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oral TYK2 Inhibitors Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Oral TYK2 Inhibitors Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Bristol Myers Squibb
  • Galapagos NV
  • Takeda (Nimbus Therapeutics)
  • Ventyx Biosciences
  • Changzhou Hengbang Pharmaceutical
  • Highlightll Pharma
  • InnoCare
  • Inventisbio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral TYK2 Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral TYK2 Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral TYK2 Inhibitors Market by Type
  6. 1.3.1 Single-target Inhibitors
  7. 1.3.2 Dual-target Inhibitors
  8. 1.4 Global Oral TYK2 Inhibitors Market Size by Type
  9. 1.4.1 Global Oral TYK2 Inhibitors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral TYK2 Inhibitors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral TYK2 Inhibitors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral TYK2 Inhibitors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral TYK2 Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral TYK2 Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral TYK2 Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral TYK2 Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral TYK2 Inhibitors Industry Trends
  2. 2.2 Oral TYK2 Inhibitors Industry Drivers
  3. 2.3 Oral TYK2 Inhibitors Industry Opportunities and Challenges
  4. 2.4 Oral TYK2 Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral TYK2 Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral TYK2 Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Oral TYK2 Inhibitors Price (2021-2026)
  4. 3.4 Global Oral TYK2 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral TYK2 Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Oral TYK2 Inhibitors Company, Product Type & Application
  7. 3.7 Global Oral TYK2 Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral TYK2 Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral TYK2 Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral TYK2 Inhibitors Tier 1, Tier 2, and Tier 3
4 Oral TYK2 Inhibitors Regional Status and Outlook
  1. 4.1 Global Oral TYK2 Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral TYK2 Inhibitors Historic Market Size by Region
  3. 4.2.1 Global Oral TYK2 Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral TYK2 Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral TYK2 Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral TYK2 Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Oral TYK2 Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral TYK2 Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral TYK2 Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral TYK2 Inhibitors by Application
  1. 5.1 Oral TYK2 Inhibitors Market by Application
  2. 5.1.1 Psoriasis
  3. 5.1.2 Systemic Lupus Erythematosus
  4. 5.1.3 Dermatitis
  5. 5.1.4 Arthritis
  6. 5.1.5 Others
  7. 5.2 Global Oral TYK2 Inhibitors Market Size by Application
  8. 5.2.1 Global Oral TYK2 Inhibitors Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Oral TYK2 Inhibitors Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Oral TYK2 Inhibitors Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Oral TYK2 Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Oral TYK2 Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Oral TYK2 Inhibitors Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Oral TYK2 Inhibitors Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Oral TYK2 Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol Myers Squibb
  2. 6.1.1 Bristol Myers Squibb Company Information
  3. 6.1.2 Bristol Myers Squibb Business Overview
  4. 6.1.3 Bristol Myers Squibb Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolio
  6. 6.1.5 Bristol Myers Squibb Recent Developments
  7. 6.2 Galapagos NV
  8. 6.2.1 Galapagos NV Company Information
  9. 6.2.2 Galapagos NV Business Overview
  10. 6.2.3 Galapagos NV Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Galapagos NV Oral TYK2 Inhibitors Product Portfolio
  12. 6.2.5 Galapagos NV Recent Developments
  13. 6.3 Takeda (Nimbus Therapeutics)
  14. 6.3.1 Takeda (Nimbus Therapeutics) Company Information
  15. 6.3.2 Takeda (Nimbus Therapeutics) Business Overview
  16. 6.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolio
  18. 6.3.5 Takeda (Nimbus Therapeutics) Recent Developments
  19. 6.4 Ventyx Biosciences
  20. 6.4.1 Ventyx Biosciences Company Information
  21. 6.4.2 Ventyx Biosciences Business Overview
  22. 6.4.3 Ventyx Biosciences Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolio
  24. 6.4.5 Ventyx Biosciences Recent Developments
  25. 6.5 Changzhou Hengbang Pharmaceutical
  26. 6.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 6.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 6.5.3 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolio
  30. 6.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 6.6 Highlightll Pharma
  32. 6.6.1 Highlightll Pharma Company Information
  33. 6.6.2 Highlightll Pharma Business Overview
  34. 6.6.3 Highlightll Pharma Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Highlightll Pharma Oral TYK2 Inhibitors Product Portfolio
  36. 6.6.5 Highlightll Pharma Recent Developments
  37. 6.7 InnoCare
  38. 6.7.1 InnoCare Company Information
  39. 6.7.2 InnoCare Business Overview
  40. 6.7.3 InnoCare Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 InnoCare Oral TYK2 Inhibitors Product Portfolio
  42. 6.7.5 InnoCare Recent Developments
  43. 6.8 Inventisbio
  44. 6.8.1 Inventisbio Company Information
  45. 6.8.2 Inventisbio Business Overview
  46. 6.8.3 Inventisbio Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Inventisbio Oral TYK2 Inhibitors Product Portfolio
  48. 6.8.5 Inventisbio Recent Developments
7 North America by Country
  1. 7.1 North America Oral TYK2 Inhibitors Sales by Country
  2. 7.1.1 North America Oral TYK2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral TYK2 Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral TYK2 Inhibitors Market Size by Country
  6. 7.2.1 North America Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral TYK2 Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral TYK2 Inhibitors Sales by Country
  2. 8.1.1 Europe Oral TYK2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral TYK2 Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral TYK2 Inhibitors Market Size by Country
  6. 8.2.1 Europe Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral TYK2 Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral TYK2 Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Oral TYK2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral TYK2 Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral TYK2 Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral TYK2 Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral TYK2 Inhibitors Sales by Country
  2. 10.1.1 South America Oral TYK2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral TYK2 Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral TYK2 Inhibitors Market Size by Country
  6. 10.2.1 South America Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral TYK2 Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral TYK2 Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Oral TYK2 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral TYK2 Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral TYK2 Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Oral TYK2 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral TYK2 Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral TYK2 Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral TYK2 Inhibitors Value Chain Analysis
  2. 12.1.1 Oral TYK2 Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral TYK2 Inhibitors Production Mode & Process
  7. 12.2 Oral TYK2 Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral TYK2 Inhibitors Distributors
  10. 12.2.3 Oral TYK2 Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst